Skip to content

Using day-to-day behavior on smartphones to improve epilepsy management

Using day-to-day behavior on smartphones to improve epilepsy management - Smartphone behavior and epilepsy management

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON54668
Enrollment
100
Registered
2020-09-28
Start date
2020-10-02
Completion date
Unknown
Last updated
2025-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

convulsions epileptic seizures

Interventions

None listed

Sponsors

Stichting Epilepsie Instellingen Nederland
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - >= 18 years of age - clinical diagnosis of refractory focal epilepsy meeting ILAE criteria - supported by at least one of the following; (1) interictal EEG with epileptiform discharges, (2) epileptogenic lesion on MRI corresponding to the presumed seizure onset zone, or (3) seizure recorded during a video-EEG - have a seizure frequency of >= 1 per month - only one seizure type, or in case of multiple seizure types only seizures that correspond to one probable onset zone (e.g. focal and focal to bilateral tonic-clonic seizures) - have daytime seizures (exclusively or both daytime and night-time seizures) - mentally competent and with no learning disabilities - able to keep a seizure diary including time and date (as judged by the treating physician) - have an Android-operating smartphone - use their phone with at least 5 distinct smartphone apps at a minimum of 5 days a week - gave informed consent

Exclusion criteria

Exclusion criteria: not fulfilling the above mentioned inclusion criteria

Design outcomes

Primary

MeasureTime frame
Change in touchscreen interactions (tapping speed, texting speed, apps used, location, sleep-wake cycles) surrounding reported epileptic seizures.

Secondary

MeasureTime frame
Niet van toepassing

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)